Featured Stories
Dark Chemical Matter and Colon Cancer
Seven years ago, Jason Crawford, PhD, began chasing a ghost: A bacterial toxin named colibactin.
Ting: Liver Cyst
An ultrasound detected that Ting not only had bladder stones, but a cyst in her bile duct. She consulted with a general surgeon, who said that her cyst was very unusual and that she would be better served by a liver specialist at Yale.
Jean: Pancreatic Cancer Survivor
A simple blood test found that Jean's CA 19-9 levels were very high, indicating there might possibly be a chance that she had cancer cells in her body.
New Insights into Pancreatic Cancer
Pancreatic cancer remains one of the most deadly cancers, with a 5 year survival rate of less than 10 percent. Part of the explanation is that the disease rarely shows early symptoms, and there is no reliable way to detect its initial stages.
Striving to Improve Outcomes in Colon Cancer
After a patient is diagnosed with colon cancer, do diet and lifestyle continue to matter in terms of a patient’s recovery, survival, and the chances of cancer recurrence?
Paul Varsanik: Esophageal Cancer
The use of trimodality treatment for patients with esophageal cancer has been shown to increase survival and offer the potential for long-term cure.
A Surprising Defense Against Pancreatic Cancer
A study published recently by Harvey Risch, MD, PhD, Professor of Epidemiology, and several colleagues, signals a promising, inexpensive possibility for changing the numbers for pancreatic cancer: aspirin.
Robert: Esophageal Cancer Survivor
An endoscopy revealed Robert had a large tumor that had migrated to his surrounding lymph nodes and was too large to remove.
01:13:33
HBOC Cancer Risk Part II
| Breast Reconstruction Options | Dr. Tomer Avraham Pancreatic Cancer | Dr. James Farrell Risks, Surveillance: Screening for Men w/ HBC Syndromes, melanoma, prostate, and others | Amy Killie Facilitator | Claire Healy
|